We are live on
!
Find out more
MC
Muhlenkamp & Co Portfolio holdings
AUM
$380M
1-Year Est. Return
43.74%
This Fund
S&P 500
This Quarter
Est. Return
+0.56%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$256M
AUM Growth
+$11.1M
(+4.5%)
Cap. Flow
+$15.3M
Cap. Flow
% of AUM
5.98%
Top 10 Holdings %
Top 10 Hldgs %
51.66%
Holding
60
New
7
Increased
2
Reduced
29
Closed
6
Top Buys
| 1 |
SPDR Gold Trust
GLD
|
+$10.5M |
| 2 |
McKesson
MCK
|
+$8.1M |
| 3 |
Community Health Systems
CYH
|
+$5.53M |
| 4 |
CELG
Celgene Corp
CELG
|
+$2.05M |
| 5 |
QHC
Quorum Health Corporation
QHC
|
+$1.09M |
Top Sells
| 1 |
BHI
Baker Hughes
BHI
|
+$4.86M |
| 2 |
Allegiant Air
ALGT
|
+$2.85M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$2.18M |
| 4 |
MacroGenics
MGNX
|
+$1.16M |
| 5 |
Bread Financial
BFH
|
+$97.3K |
Sector Composition
| 1 | Healthcare | 32.06% |
| 2 | Technology | 19.54% |
| 3 | Consumer Discretionary | 10.46% |
| 4 | Industrials | 10.26% |
| 5 | Financials | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bread Financial
BFH
$3.97B
| $23.7M | 9.25% |
151,430
-585
| -0.4% | -$97.3K |
|
2
Gilead Sciences
GILD
$169B
| $18.1M | 7.07% |
217,000
-990
| -0.5% | -$87.9K |
|
3
Apple
AAPL
$4.89T
| $14.4M | 5.62% |
602,520
-2,296
| -0.4% | -$57.1K |
|
|
4
Bristol-Myers Squibb
BMY
$124B
| $13.3M | 5.21% |
181,340
-30,860
| -15% | -$2.18M |
|
5
Microsoft
MSFT
$2.98T
| $12.1M | 4.71% |
235,538
-1,125
| -0.5% | -$58.5K |
|
6
ON Semiconductor
ON
$34.3B
| $11.1M | 4.35% |
1,261,735
-7,255
| -0.6% | -$69K |
|
|
7
SPDR Gold Trust
GLD
$130B
| $11M | 4.31% |
+87,320
| New | +$10.5M |
|
|
HBI
8
DELISTED
Hanesbrands
HBI
| $10M | 3.92% |
399,155
-2,315
| -0.6% | -$63.1K |
|
|
LCI
9
DELISTED
Lannett Company, Inc.
LCI
| $9.62M | 3.76% |
101,101
-549
| -0.5% | -$47K |
|
10
Teva Pharmaceuticals
TEVA
$37.5B
| $8.87M | 3.47% |
176,655
-505
| -0.3% | -$26.9K |
|
|
SAVE
11
DELISTED
Spirit Airlines, Inc.
SAVE
| $8.64M | 3.37% |
192,555
-760
| -0.4% | -$33.8K |
|
|
12
McKesson
MCK
$98.5B
| $8.62M | 3.37% |
+46,183
| New | +$8.1M |
|
13
UnitedHealth
UNH
$384B
| $8.5M | 3.32% |
60,220
-260
| -0.4% | -$34.7K |
|
14
Rush Enterprises Class A
RUSHA
$6.19B
| $8.3M | 3.24% |
866,255
| – | – |
|
15
Celanese
CE
$5.02B
| $8.15M | 3.18% |
124,570
-700
| -0.6% | -$48.6K |
|
|
NSR
16
DELISTED
Neustar Inc
NSR
| $7.23M | 2.83% |
307,680
-1,710
| -0.6% | -$40.7K |
|
17
Invesco BuyBack Achievers ETF
PKW
$1.69B
| $6.3M | 2.46% |
139,410
-1,260
| -0.9% | -$57.3K |
|
|
WCIC
18
DELISTED
WCI Communities, Inc.
WCIC
| $6.13M | 2.39% |
362,670
+2,346
| +0.7% | +$40.1K |
|
19
Biogen
BIIB
$30.8B
| $5.73M | 2.24% |
23,703
-150
| -0.6% | -$39.5K |
|
|
20
Allegiant Air
ALGT
$2.83B
| $5.15M | 2.01% |
34,001
-18,475
| -35% | -$2.85M |
|
21
Universal Display
OLED
$3.73B
| $5.08M | 1.98% |
74,930
-645
| -0.9% | -$39.6K |
|
22
Delta Air Lines
DAL
$57B
| $4.87M | 1.9% |
133,705
-545
| -0.4% | -$23.2K |
|
|
GMLP
23
DELISTED
Golar LNG Partners LP
GMLP
| $4.87M | 1.9% |
265,405
-3,690
| -1% | -$62.6K |
|
24
SLB Ltd
SLB
$70.4B
| $4.75M | 1.86% |
60,080
-230
| -0.4% | -$17.6K |
|
|
25
Community Health Systems
CYH
$476M
| $4.55M | 1.78% |
+377,245
| New | +$5.53M |
|
Similar funds
AC
MW
EAM
RWA
CSWG
BP
NICM
KFS
Muhlenkamp & Co's Q2 2016 Portfolio in Review
As of Q2 2016, Muhlenkamp & Co held 60 positions worth $256M, up 4.5% from $245M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Muhlenkamp & Co deployed $15.3M of net new capital in Q2 2016, opening 7 new positions and adding to 2 existing holdings. Its largest new stake was SPDR Gold Trust: 87,320 shares worth $11M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Allegiant Air, an estimated $2.85M trimmed.
- Muhlenkamp & Co's largest Q2 2016 buy was SPDR Gold Trust: 87,320 shares worth $11M.
- Muhlenkamp & Co added most to WCI Communities, Inc. in Q2 2016, an estimated $40.1K increase.
- Muhlenkamp & Co's biggest Q2 2016 reduction was Allegiant Air, cutting an estimated $2.85M.
- Muhlenkamp & Co fully exited Baker Hughes in Q2 2016, selling an estimated $4.86M.
- Muhlenkamp & Co's ten largest holdings make up 52% of its $256M portfolio in Q2 2016.
- Muhlenkamp & Co opened 7 new positions and closed 6 in Q2 2016.
- Muhlenkamp & Co's portfolio value rose 4.5% quarter-over-quarter to $256M.
Based on Muhlenkamp & Co's 13F filing for Q2 2016, filed 9 Aug 2016.